WHO recommends use of innovative HIV drug
Based
on new evidence assessing benefits and risks, the World Health Organisation
(WHO) has recommended the use of the HIV drug dolutegravir ...
|
View article...
Updates & Legacy — Stigmabase is a Canadian Non-Governmental & Nonprofit Initiative. Our mission is to inform about stigma around the world and make the data collected accessible for researchers. Stigmabase is very attentive to misinformation and lists only reliable sources. — The marginalization of individuals or categories of individuals is a too common phenomenon. Millions of people are facing this problem around the world and many complex factors are involved.
Based
on new evidence assessing benefits and risks, the World Health Organisation
(WHO) has recommended the use of the HIV drug dolutegravir ...
|